Diageo Gains, Novo Rises, Siemens Energy Up - podcast episode cover

Diageo Gains, Novo Rises, Siemens Energy Up

Nov 10, 20254 min
--:--
--:--
Download Metacast podcast app
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episode description

On this episode of Stock Movers:
- Diageo named Dave Lewis, the former head of supermarket chain Tesco, as its new CEO as the maker of Guinness stout and Johnnie Walker seeks to reboot after a period of turmoil.
- Novo Nordisk shares rose after the Danish drug-maker withdrew from a $10 billion takeover battle for obesity drug developer Metsera, clearing the way for Pfizer.
- Siemens Energy shares continue to look undervalued, despite more than doubling since the start of the year, Jefferies writes in note as upgrades to buy from hold.

See omnystudio.com/listener for privacy information.

Transcript

Speaker 1

Bloomberg Audio Studios, Podcasts, radio News.

Speaker 2

The Stock Movers Report, your roundup of companies making moves in the stock market, harnessing the power of Bloomberg Data.

Speaker 3

Let's have a look at some of the socks on the move today here in Europe. I'm Caroline hep Get alongside Tom McKenzie, and we're joined by Bloomberg reporter Chloe Malay. Good morning, Chloe, So let's talk about the British drinks maker Diaggio. Looks like investors are very pleased with the announcement of a new CEO. I suppose he's got experience filling the shelves with Johnny Walker bottles, doesn't he.

Speaker 4

Yeah, absolutely, So the chars are up quite a lot this morning because investors seems to be really keen on this new CEO, Dave Lewis, who has, as you said, really extensive retail experience and a strong a track record. So he was at UNILEVERA for a really long while. But what he's really known for is turning around Tesco,

where he was CEO as well. So he managed to run things around after an accounting a scandal that had sent the Chez undrink for Tesco, and he managed to boost profit and sales, and he earned the nickname of Drastic Dave for his program of job cuts and store closures. So we'll see if he does the same at Dare Joe and This have said that the appointment was a good move and noted that it brings the uncertainty over

that leadership transition at the company to an end. So Lewis will now need to reset targets and figure out a way of out of the slowdown in that drink's market. Of course, Dado has not been doing very well recently. The shares are down about thirty percent over the last year, and it lowered its outlook just last week, noting a lot of weakness in the US in China. But it seems to investors are confident that Lewis can maybe turn things around and revive the fortunes of jad Joe and in.

Speaker 1

The pharmacols pharmaceutical space at Chloe. This incredible kind of runoff between Nova and Orders. Can Pfizer bidding for a weight loss drugs company met Sarah and it seems like Nova and Ores a square they've thrown. They They've kind of thrown the towel in and so Fizer, we're going to go ahead with this one of the details.

Speaker 4

Yeah, So investors are actually quite happy that Nova will not be purchasing with Sarah. So shares rose for and overdoorders this morning after it withdrew over the weekend. It's ten billion dollar offer for mid Sarah the AVCT startup. So that means that Pfizer will now be buying the company.

So that's the end of quite an interesting takeover battle that has been that has been followed really closely by the market over the last few weeks, and it seems that investors are not seeing this as a setback for an Overnordics, but more over walking away from something that might have been quite difficult to pull off. Maybe, so there were concerns around overpaying as the take of a

battle really intensified last week. And then Metzarah had also said that it got a call from the us A Federal Trade Commission saying that there were potential regulatory risk with the deal structure that was proposed by an over Nordisks. So because of those price concerns, those regulatory concerns, potential antitrust concerns as well, that withdraw is actually being welcome with a sense of relief by no Over Nordisk investors.

Speaker 3

Interesting and then lastly on Zeman's Energy, what's been of note today?

Speaker 4

Yeah, it was a race to buy at Jeffries in so that that led the shares a higher this morning. So and Jeffreys analyst said that the shares were significantly undervalued and that is despite them more than doubling since the start of the year. And they said that the portfolio from Semens Energy addresses all of the main challenges that we have got in the energy sector, which means

that it should continue to see really high demands. So there's been a real increase in grid investments, in power generation investments and that has meant a lot more orders and record backlogs for Semens Energy, and analysts expect this to continue into twenty twenty six. Just last week we had Morgan Stanley analysts also increasing their price target for the company, saying the order backlog was in really good shape. So things are looking great for Semen's Energy.

Speaker 2

The Stock Mover's Report from Bloomberg Radio. Check back with us throughout the day for the latest roundup of companies making news on Wall Street and for the SATIS market moving headlines. Listen to Bloomberg Radio Live. Catch us on YouTube, Bloomberg dot com, and on Applecarplay and Android Auto with the Bloomberg Business app.

Transcript source: Provided by creator in RSS feed: download file
For the best experience, listen in Metacast app for iOS or Android